ZIRANU, PINA
 Distribuzione geografica
Continente #
EU - Europa 33.800
NA - Nord America 2.807
AS - Asia 1.443
SA - Sud America 238
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 49
OC - Oceania 1
Totale 38.473
Nazione #
IT - Italia 33.172
US - Stati Uniti d'America 2.680
SG - Singapore 628
CN - Cina 344
BR - Brasile 178
VN - Vietnam 178
SE - Svezia 161
DE - Germania 92
FR - Francia 75
GB - Regno Unito 71
CA - Canada 62
IN - India 58
HK - Hong Kong 50
FI - Finlandia 48
BD - Bangladesh 38
NL - Olanda 36
MX - Messico 23
ES - Italia 21
IE - Irlanda 20
IQ - Iraq 20
RU - Federazione Russa 19
PL - Polonia 17
UA - Ucraina 17
CO - Colombia 15
KR - Corea 15
TR - Turchia 15
AT - Austria 14
EC - Ecuador 14
JP - Giappone 14
ZA - Sudafrica 13
AR - Argentina 12
IL - Israele 12
BE - Belgio 10
MA - Marocco 10
PK - Pakistan 10
CR - Costa Rica 9
ID - Indonesia 8
VE - Venezuela 8
IR - Iran 6
PH - Filippine 6
GT - Guatemala 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
PR - Porto Rico 4
SA - Arabia Saudita 4
SC - Seychelles 4
SV - El Salvador 4
UZ - Uzbekistan 4
BZ - Belize 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KZ - Kazakistan 3
MK - Macedonia 3
MY - Malesia 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
DM - Dominica 2
EG - Egitto 2
GP - Guadalupe 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 38.340
Città #
Cagliari 31.677
Uta 1.181
Ashburn 393
Singapore 373
Dallas 245
San Jose 235
New York 103
Boardman 101
Fairfield 100
Council Bluffs 90
Beijing 84
Los Angeles 83
Nyköping 83
Chandler 78
Ho Chi Minh City 56
Houston 55
Seattle 55
Santa Clara 48
Hong Kong 47
The Dalles 42
Wilmington 42
Rome 40
Woodbridge 40
Hanoi 34
Helsinki 34
Orem 32
Cambridge 31
Chicago 25
Amsterdam 24
Boston 24
Frankfurt am Main 24
Shanghai 23
Buffalo 21
Lauterbourg 21
Hefei 20
London 20
Columbus 19
Milan 18
Nuremberg 17
Phoenix 17
Redondo Beach 17
São Paulo 17
Toronto 17
Dearborn 16
Denver 16
Guangzhou 16
Munich 16
Dublin 15
Montreal 15
Seoul 15
Warsaw 14
Brooklyn 12
Dong Ket 12
Pune 12
Chennai 11
Düsseldorf 11
Poplar 11
San Diego 11
Ann Arbor 10
Atlanta 10
Jacksonville 10
New Delhi 9
Paris 9
Tokyo 9
Baghdad 8
Johannesburg 8
Lappeenranta 8
Mexico City 8
Naples 8
Rio de Janeiro 8
Salt Lake City 8
Stockholm 8
Turin 8
Charlotte 7
Da Nang 7
Haiphong 7
Manchester 7
Quito 7
Selargius 7
Belo Horizonte 6
Casablanca 6
Lahore 6
Medellín 6
Nanjing 6
Orlando 6
Princeton 6
San José 6
Shenzhen 6
Wuhan 6
Zhengzhou 6
Bexley 5
Biên Hòa 5
Boulder 5
Brussels 5
Centro 5
Cleveland 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Istanbul 5
Totale 36.196
Nome #
Clustered protocadherins methylation alterations in cancer 3.350
BRAF-mutant colorectal cancer, a different breed evolving 3.259
Molecular-biology-driven treatment for metastatic colorectal cancer 2.795
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.734
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.393
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.151
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.132
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study 1.876
Immunotherapy and Cancer: The Multi-Omics Perspective 1.649
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.557
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.245
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 1.072
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 1.006
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 978
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 977
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 922
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 793
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 778
Uncovering key targets of success for immunotherapy in pancreatic cancer 742
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 665
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 637
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 518
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 458
CD44: A New Prognostic Marker in Colorectal Cancer? 293
Early taxane exposure and neurotoxicity in breast cancer patients 247
A new prognostic score for biliary tract cancer: a multicenter experience 238
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 236
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 231
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 223
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 220
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 201
Medical management of malignant bowel obstruction: our center experience 198
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 184
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 157
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 157
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 156
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 139
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 137
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 136
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 123
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 120
The role of metastasectomy in patients with early onset metastatic colorectal cancer 118
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 118
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis 63
L1cam expression in the peritumoral stromal cells of the microenvironment of colorectal cancer: a new target for oncologists? 49
L1CAM expression identifies different colorectal tumor subgroups 42
Totale 38.473
Categoria #
all - tutte 55.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.840 0 0 0 0 142 126 101 128 218 252 312 561
2022/20233.974 319 654 564 307 286 357 175 306 275 290 290 151
2023/20245.431 233 115 136 192 296 560 565 2.165 169 229 374 397
2024/202510.559 3.026 3.284 1.030 1.034 484 701 448 51 122 109 76 194
2025/20264.190 329 255 372 376 300 298 796 387 235 383 276 183
2026/2027930 75 193 214 399 49 0 0 0 0 0 0 0
Totale 38.473